Literature DB >> 21163715

Gut microbiota and probiotics in chronic liver diseases.

Claudia Cesaro1, Angelo Tiso, Anna Del Prete, Rita Cariello, Concetta Tuccillo, Gaetano Cotticelli, Camillo Del Vecchio Blanco, Carmelina Loguercio.   

Abstract

There is a strong relationship between liver and gut: the portal system receives blood from the gut, and intestinal blood content activates liver functions. The liver, in turn, affects intestinal functions through bile secretion into the intestinal lumen. Alterations of intestinal microbiota seem to play an important role in induction and promotion of liver damage progression, in addition to direct injury resulting from different causal agents. Bacterial overgrowth, immune dysfunction, alteration of the luminal factors, and altered intestinal permeability are all involved in the pathogenesis of complications of liver cirrhosis, such as infections, hepatic encephalopathy, spontaneous bacterial peritonitis, and renal failure. Probiotics have been suggested as a useful integrative treatment of different types of chronic liver damage, for their ability to augment intestinal barrier function and prevent bacterial translocation. This review summarizes the main literature findings about the relationships between gut microbiota and chronic liver disease, both in the pathogenesis and in the treatment by probiotics of the liver damage.
Copyright © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21163715     DOI: 10.1016/j.dld.2010.10.015

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  60 in total

Review 1.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 2.  Gut microbiota modulate the immune effect against hepatitis B virus infection.

Authors:  D Xu; Y Huang; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-14       Impact factor: 3.267

Review 3.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

4.  Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.

Authors:  James H Tabibian; Steven P O'Hara; Christy E Trussoni; Pamela S Tietz; Patrick L Splinter; Taofic Mounajjed; Lee R Hagey; Nicholas F LaRusso
Journal:  Hepatology       Date:  2015-08-10       Impact factor: 17.425

5.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

Review 6.  Gut microbiota-related complications in cirrhosis.

Authors:  Isabel Gómez-Hurtado; José Such; Yolanda Sanz; Rubén Francés
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

7.  Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis.

Authors:  Hironori Koga; Yoshitaka Tamiya; Keiichi Mitsuyama; Masahiko Ishibashi; Satoshi Matsumoto; Akemi Imaoka; Taeko Hara; Masatoshi Nakano; Kazutoshi Ooeda; Yoshinori Umezaki; Michio Sata
Journal:  Hepatol Int       Date:  2012-11-21       Impact factor: 6.047

8.  Hepatoprotective Effects of Selenium-Enriched Probiotics Supplementation on Heat-Stressed Wistar Rat Through Anti-Inflammatory and Antioxidant Effects.

Authors:  Rahmani Mohammad Malyar; Emal Naseri; Hu Li; Ilyas Ali; Rawan Ahmad Farid; Dandan Liu; Khushdil Maroof; Maazullah Nasim; Sayed Attaul Haq Banuree; Kehe Huang; Kevin J Waldron; Xingxiang Chen
Journal:  Biol Trace Elem Res       Date:  2020-11-07       Impact factor: 3.738

9.  The effect of moderate-dose aflatoxin B1 and Salmonella Enteritidis infection on intestinal permeability in broiler chickens.

Authors:  J O Hernández-Ramírez; M J Nava-Ramírez; R Merino-Guzmán; G Téllez-Isaías; A Vázquez-Durán; A Méndez-Albores
Journal:  Mycotoxin Res       Date:  2019-07-11       Impact factor: 3.833

10.  Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure.

Authors:  Yuzhen Wang; Jiming Xie; Yunxu Li; Shichao Dong; Huan Liu; Junna Chen; Yan Wang; Shimin Zhao; Yong Zhang; Heping Zhang
Journal:  Eur J Nutr       Date:  2015-04-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.